Disease-specific autoantibody biomarkers of multiple sclerosis are present years before disease onset

被引：0

作者：

Sowa, G. ^{[1
]}

Zamecnik, C. ^{[2
]}

Bair, R. ^{[2
]}

Abdelhak, A. ^{[3
,4
]}

Bartley, C. ^{[5
,6
]}

Dandekar, R. ^{[2
]}

Rackaityte, E. ^{[7
]}

Loudermilk, R. ^{[2
]}

Wapniarski, A. ^{[2
]}

Alvarenga, B. ^{[3
]}

Zorn, K. ^{[7
]}

Alexander, J. ^{[2
]}

Fouassier, C. ^{[2
]}

Cree, B. ^{[2
]}

Green, A. ^{[2
]}

DeRisi, J. ^{[7
,8
]}

Hauser, S. ^{[2
]}

Wallin, M. ^{[9
,10
,11
]}

Wilson, M. ^{[2
,3
]}

机构：

[1] Northwestern Univ, Dept Med, McGaw Med Ctr, Chicago, IL 60611 USA

[2] Weill Inst Neurosci, Dept Neurol, San Francisco, CA USA

[3] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA

[4] Ulm Univ Hosp, Dept Neurol, Ulm, Germany

[5] Weill Inst Neurosci, Dept Psychiat & Behav Sci, San Francisco, CA USA

[6] Howard Hughes Med Inst, Chevy Chase, MD USA

[7] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA

[8] Chan Zuckerberg Biohub, San Francisco, CA USA

[9] VA Multiple Sclerosis Ctr Excellence East, Washington, DC USA

[10] George Washington Univ, Sch Med, Washington, DC USA

[11] Univ Maryland, Dept Neurol, Baltimore, MD 21201 USA

来源：

MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

O112

引用

页码：87 / 88

页数：2

共 50 条

[41] Multiple sclerosis: Disease biomarkers as indicated by pathophysiology
Berger, Thomas
Reindl, Markus
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 259 (1-2) : 21 - 26
[42] Relevance of biomarkers in disease progression in multiple sclerosis
Kanodia, A. K.
EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (01) : 7 - 8
[43] Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis
Zeydan, Burcu
Lowe, Val J.
Reichard, Ross R.
Przybelski, Scott A.
Lesnick, Timothy G.
Schwarz, Christopher G.
Senjem, Matthew L.
Gunter, Jeffrey L.
Parisi, Joseph E.
Machulda, Mary M.
Vemuri, Prashanthi
Mielke, Michelle M.
Knopman, David S.
Petersen, Ronald C.
Jack, Clifford R., Jr.
Kantarci, Orhun H.
Kantarci, Kejal
ANNALS OF NEUROLOGY, 2020, 87 (04) : 556 - 567
[44] Complement components as biomarkers of disease in multiple sclerosis
Ingram, Gillian
Hakobyan, Svetlana
Hirst, Claire
Robertson, Neil
Morgan, B. Paul
MOLECULAR IMMUNOLOGY, 2008, 45 (16) : 4176 - 4177
[45] MULTIPLE SCLEROSIS AND PREGNANCY. DISEASE BIOMARKERS
Deleva, Denislava
Kolyovska, Vera
Sultanov, Borislav
COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2012, 65 (06): : 865 - 870
[46] Validation of disease-specific biomarkers for the early detection of bronchopulmonary dysplasia
Alida S. D. Kindt
Kai M. Förster
Suzan C. M. Cochius-den Otter
Andreas W. Flemmer
Stefanie M. Hauck
Andrew Flatley
Juliette Kamphuis
Stefan Karrasch
Jürgen Behr
Axel Franz
Christoph Härtel
Jan Krumsiek
Dick Tibboel
Anne Hilgendorff
Pediatric Research, 2023, 93 : 625 - 632
[47] Disease-specific non–reducing end carbohydrate biomarkers for mucopolysaccharidoses
Roger Lawrence
Jillian R Brown
Kanar Al-Mafraji
William C Lamanna
James R Beitel
Geert-Jan Boons
Jeffrey D Esko
Brett E Crawford
Nature Chemical Biology, 2012, 8 : 197 - 204
[48] Validation of disease-specific biomarkers for the early detection of bronchopulmonary dysplasia
Kindt, Alida S. D.
Foerster, Kai M.
Cochius-den Otter, Suzan C. M.
Flemmer, Andreas W.
Hauck, Stefanie M.
Flatley, Andrew
Kamphuis, Juliette
Karrasch, Stefan
Behr, Juergen
Franz, Axel
Haertel, Christoph
Krumsiek, Jan
Tibboel, Dick
Hilgendorff, Anne
PEDIATRIC RESEARCH, 2023, 93 (03) : 625 - 632
[49] Shifting paradigms in multiple sclerosis: from disease-specific, through population-specific toward patient-specific
Golan, Daniel
Staun-Ram, Elsebeth
Miller, Ariel
CURRENT OPINION IN NEUROLOGY, 2016, 29 (03) : 354 - 361
[50] Application of glatiramer acetate to neurodegenerative diseases beyond multiple sclerosis - The need for disease-specific approaches
Schwartz, Michal
Bukshpan, Shay
Kunis, Gilad
BIODRUGS, 2008, 22 (05) : 293 - 299

← 1 2 3 4 5 →